TR201203084A2 - Formulations containing cefditoren pivoxil and clavulanic acid. - Google Patents

Formulations containing cefditoren pivoxil and clavulanic acid.

Info

Publication number
TR201203084A2
TR201203084A2 TR2012/03084A TR201203084A TR201203084A2 TR 201203084 A2 TR201203084 A2 TR 201203084A2 TR 2012/03084 A TR2012/03084 A TR 2012/03084A TR 201203084 A TR201203084 A TR 201203084A TR 201203084 A2 TR201203084 A2 TR 201203084A2
Authority
TR
Turkey
Prior art keywords
clavulanic acid
formulations containing
cefditoren pivoxil
containing cefditoren
pivoxil
Prior art date
Application number
TR2012/03084A
Other languages
Turkish (tr)
Inventor
Bi̇lgi̇ç Mahmut
Original Assignee
Bi̇lgi̇ç Mahmut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bi̇lgi̇ç Mahmut filed Critical Bi̇lgi̇ç Mahmut
Priority to TR2012/03084A priority Critical patent/TR201203084A2/en
Publication of TR201203084A2 publication Critical patent/TR201203084A2/en

Links

Abstract

Mevcut buluş, aktif ajan olarak sefditoren pivoksil ve klavulanik asit ve/veya türevlerini içeren farmasötik bileşimlere ilişkindir.The present invention relates to pharmaceutical compositions comprising cefditoren pivoxil and clavulanic acid and / or derivatives as the active agent.

TR2012/03084A 2010-05-14 2010-05-14 Formulations containing cefditoren pivoxil and clavulanic acid. TR201203084A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TR2012/03084A TR201203084A2 (en) 2010-05-14 2010-05-14 Formulations containing cefditoren pivoxil and clavulanic acid.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2012/03084A TR201203084A2 (en) 2010-05-14 2010-05-14 Formulations containing cefditoren pivoxil and clavulanic acid.

Publications (1)

Publication Number Publication Date
TR201203084A2 true TR201203084A2 (en) 2012-05-21

Family

ID=47003504

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2012/03084A TR201203084A2 (en) 2010-05-14 2010-05-14 Formulations containing cefditoren pivoxil and clavulanic acid.

Country Status (1)

Country Link
TR (1) TR201203084A2 (en)

Similar Documents

Publication Publication Date Title
MX2015008627A (en) Boronic acid derivatives and therapeutic uses thereof.
WO2014186742A3 (en) Anhydrous hydrogel composition
MX2016016666A (en) Boronic acid derivatives and therapeutic uses thereof.
MX2016015093A (en) Boronic acid derivatives and therapeutic uses thereof.
MX2015008628A (en) Boronic acid derivatives and therapeutic uses thereof.
MX348823B (en) Stable formulations of linaclotide.
AR081681A1 (en) METHODS AND COMPOSITIONS FOR THE INTRATECAL ADMINISTRATION OF b-GALACTOCEREBROSIDASA
EA201270741A1 (en) ORAL COMPOSITIONS AND LIPOPHYL SALTS OF METHylNALTREX
TR200806298A2 (en) Pharmaceutical formulation
MX2012001660A (en) Linaclotide-containing formulations for oral administration.
EA201590805A1 (en) COMPOSITION WITH IMMEDIATE AND PROLONGED DELIVERY
MY157673A (en) Pharmaceutical compositions comprising hydromorphone and naloxone
MX2016001422A (en) Pharmaceutical compositions of fingolimod.
WO2011142731A3 (en) Formulations comprising a third generation cephalosporin and clavulanic acid
TR201009394A2 (en) Improved montelukast formulations.
WO2011139249A3 (en) Pharmaceutical composition comprising cefdinir
MX2019012375A (en) Lfa-1 inhibitor formulations.
TR200909785A1 (en) Pharmaceutical compositions containing cefdinir as the active agent.
TR201203084A2 (en) Formulations containing cefditoren pivoxil and clavulanic acid.
EA201500446A1 (en) PHARMACEUTICAL COMPOSITION TO REDUCE N-OXIDE TRIMETYLAMINE LEVEL
TR201009399A2 (en) Rapidly soluble effervescent rosuvastatin formulations.
WO2011152805A3 (en) Pharmaceutical composition comprising cefpodoxime proxetil and clavulanic acid
TR201109160A2 (en) New pharmaceutical compositions containing eplerenone.
TR201203087A2 (en) Ceftibutene and clavulanic acid formulations.
TR201010859A2 (en) Tablet forms containing cefdinir.